Previous Close | 0.0100 |
Open | 0.0100 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 70.00 |
Expire Date | 2024-05-17 |
Day's Range | 0.0100 - 0.0100 |
Contract Range | N/A |
Volume | |
Open Interest | 832 |
Discover how Legend Biotech's robust Q1 performance and strategic initiatives are setting the stage for sustained growth.
Q1 2024 Legend Biotech Corp Earnings Call
SOMERSET, N.J., May 13, 2024--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2024 unaudited financial results and key corporate highlights.